Результаты поиска

MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation.

BACKGROUND: Relapse is a frequent occurrence in autologous hematopoietic stem cell transplantation (AHSCT), and early relapse after AHSCT results in poor survival and low quality of life. Predictive marker determination for AHSCT outcomes could be helpful in the prevention of relapse through personalized medicine. Here the predictive value of circulatory microRNAs (miRs) expression for AHSCT outcomes was studied. METHODS: 50 MM and lymphoma candidates for AHSCT participated in this study. Two plasma samples were obtained before AHSCT from each candidate; one before mobilization and the other

Совпадение в полном тексте источника
… Feng Y Zhong M Zeng S Wang L Liu P Xiao X Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance Epigenomics 2019 11 1 35 51 10.2217/epi-2018-0123 30211623 26. …

Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?

Cholangiocarcinoma (CCA) is a refractory cancer with limited treatment options and poorly understood molecular mechanisms underlying tumor development. The most effective treatment is surgical resection; however, patients are highly prone to recurrence. Moreover, considering that most patients are diagnosed in advanced stages, treatment options are restricted to palliative care, which results in poor prognosis. Due to the limited effect of chemotherapy and radiotherapy, targeted therapy is becoming a hot topic in the field of biliary cancer treatment. The fibroblast growth factor/fibroblast gr

Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies.

Background: Cholangiocarcinoma (CCA) is a highly heterogeneous malignancy arising from the biliary epithelium, with an increasing incidence and poor prognosis worldwide. Recent advances in next-generation sequencing have revealed a variety of genomic alterations-such as FGFR2 fusions, IDH1 mutations, and ERBB2 amplification-that may serve as therapeutic targets. However, the influence of underlying etiologic factors, including chronic liver and biliary diseases, on the molecular landscape of CCA remains unclear. Objective: This review aimed to synthesize the current knowledge on the genomic an

Совпадение в полном тексте источника
… Integrating multi-omics data, including genomics, transcriptomics, epigenomics, and metabolomics, with real-world clinical outcomes and longitudinal patient cohorts is critical for uncovering clinically meaningful molecular subtypes. …

Диабетическая иммунотерапия Адаптация с BCG: Metabolic and Immune Reprogramming.

В настоящем обзоре клеточные и молекулярные механизмы, лежащие в основе мультидозы Bacille Calmette-Guérin (BCG), характеризуются как лечебная иммунная терапия для улучшения глицемии аутоиммунного диабета. Данные BCG чаще всего представляют собой данные клинических испытаний человека за последние годы. 15 годы в паре с механистическими представлениями. БЦЖ как вакцина имеет отличный послужной список в плане безопасности, который за сто лет был достигнут в области профилактики туберкулеза во всем мире, и за 36 Годы, были утверждены УЛХ при более высоких дозах для лечения рака мочевого пузыря. Н

Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling.

Over the past decade, there has been a qualitative improvement in the understanding of gut microbiota in cancer development and treatment. Gut microbiota regulates metabolic reprogramming that occurs in the competition between tumor cells and immune cells for essential nutrients in the tumor microenvironment (TME). Besides, gut microbiota dysbiosis is one of the key factors leading to the formation of aging environment, which has many similarities with the TME. Accumulating research findings have demonstrated that gut microbiota enhances the efficacy of cancer therapies by activating the immun

Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination.

Vitamin C (L-ascorbic acid) has been known as an antioxidant for most people. However, its physiological role is much larger and encompasses very different processes ranging from facilitation of iron absorption through involvement in hormones and carnitine synthesis for important roles in epigenetic processes. Contrarily, high doses act as a pro-oxidant than an anti-oxidant. This may also be the reason why plasma levels are meticulously regulated on the level of absorption and excretion in the kidney. Interestingly, most cells contain vitamin C in millimolar concentrations, which is much highe

Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword.

Multiple myeloma (MM) is a hematological malignancy defined by the abnormal proliferation and accumulation of plasma cells (PC) within the bone marrow (BM). While multiple myeloma impacts the bone, it is not classified as a primary bone cancer. The bone marrow microenvironment significantly influences the progression of myeloma and its treatment response. Mesenchymal stromal cells (MSCs) in this environment engage with myeloma cells and other bone marrow components via direct contact and the secretion of soluble factors. This review examines the established roles of MSCs in multiple facets of

Unraveled role of TLR7-mediated interferon signaling activation in COVID-19.

Emerging evidence underscores the critical role of Toll-like receptor 7 (TLR7)-mediated interferon (IFN) signaling in host defense against viral infections including SARS-CoV-2, through the modulation of both innate and adaptive immunity. However, the specific mechanisms by which TLR7 activation shapes SARS-CoV-2-specific immune responses, particularly via IRF-IFN pathways, remain incompletely elucidated. This review synthesizes current findings on how intrinsic TLR7-driven IFN signaling influences viral clearance, modulates adaptive immunity, and contributes to autoantibody production in COVI

Совпадение в полном тексте источника
… Sex-biased expression of the TLR7 gene in severe COVID-19 patients: Insights from transcriptomics and epigenomics . Environ. Res. 215 , 114288 . doi: 10.1016/j.envres.2022.114288 , PMID: 36152884 PMC9508271 Habeichi N. J. Amin G. Lakkis B. Kataya R. Mericskay M. Booz G. W. . ( 2024 ). … Epigenomics of conventional type-I dendritic cells depicted preferential control of TLR9 versus TLR3 response by NCoR1 through differential IRF3 activation . Cell Mol. Life Sci. 79 , 429 . doi: 10.1007/s00018-022-04424-w , PMID: 35849243 PMC9293861 Moyon Q. Sterlin D. Miyara M. Anna F. Mathian A. …

Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors.

Gastrointestinal tumors present a significant challenge for precision medicine due to their complexity, necessitating the development of more specific diagnostic tools and therapeutic agents. Recent advances have positioned coding and non-coding RNAs as emerging biomarkers for these malignancies, detectable by liquid biopsies, and as innovative therapeutic agents. Many RNA-based therapeutics, such as small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have entered clinical trials or are available on the market. This review provides a narrative examination of the diagnostic and

Совпадение в полном тексте источника
… Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis Epigenomics 2021 13 1113 1128 10.2217/epi-2021-0152 34148372 13. Upadhyay V. Raval A. Shah K. Shah F.D. Rawal R. … Circrna Hsa_Circ_0004771 Promotes Esophageal Squamous Cell Cancer Progression Via miR-339-5p/CDC25A Axis Epigenomics 2020 12 587 603 10.2217/epi-2019-0404 32050790 93. Okumura T. Kojima H. Miwa T. Sekine S. Hashimoto I. Hojo S. Nagata T. Shimada Y. …

Targeting super enhancers for liver disease: a review.

BackgroundSuper enhancers (SEs) refer to the ultralong regions of a gene accompanied by multiple transcription factors and cofactors and strongly drive the expression of cell-type-related genes. Recent studies have demonstrated that SEs play crucial roles in regulating gene expression related to cell cycle progression and transcription. Aberrant activation of SEs is closely related to the occurrence and development of liver disease. Liver disease, especially liver failure and hepatocellular carcinoma (HCC), constitutes a major class of diseases that seriously endanger human health. Currently,

EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs.

Fibrosis is a condition characterized by the excessive accumulation of extracellular matrix proteins in tissues, leading to organ dysfunction and failure. Recent studies have identified EP300, a histone acetyltransferase, as a crucial regulator of the epigenetic changes that contribute to fibrosis. In fact, EP300-mediated acetylation of histones alters global chromatin structure and gene expression, promoting the development and progression of fibrosis. Here, we review the role of EP300-mediated epigenetic regulation in multi-organ fibrosis and its potential as a therapeutic target. We discuss

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials.

Chemotherapy is one of the most established and effective treatments for almost all types of cancer. However, the elevated toxicity due to the non-tumor-associated effects, development of secondary malignancies, infertility, radiation-induced fibrosis and resistance to treatment limit the effectiveness and safety of treatment. In addition, these multiple factors significantly impact quality of life. Over the last decades, our increased understanding of cancer epigenetics has led to new therapeutic approaches and the promise of improved patient outcomes. Epigenetic alterations are commonly foun

Совпадение в полном тексте источника
… A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer 11 726–734. 10.1038/nrc3130 Bruyer A., Maes K., Herviou L., Kassambara A., Seckinger A., Cartron G., et al. (2018). … Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev. 22 50–55. 10.1016/j.gde.2012.02.008 Sankar S., Bell R., Stephens B., Zhuo R., Sharma S., Bearss D. J., et al. (2016). Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. …

Perturbing Enhancer Activity in Cancer Therapy.

Tight regulation of gene transcription is essential for normal development, tissue homeostasis, and disease-free survival. Enhancers are distal regulatory elements in the genome that provide specificity to gene expression programs and are frequently misregulated in cancer. Recent studies examined various enhancer-driven malignant dependencies and identified different approaches to specifically target these programs. In this review, we describe numerous features that make enhancers good transcriptional targets in cancer therapy and discuss different approaches to overcome enhancer perturbation.

Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions.

Companion diagnostics (CDx) plays a pivotal role in precision medicine by enabling personalized treatment plans based on individual biomarker profiles. This approach can enhance therapeutic efficacy in selected indications and may reduce healthcare expenditures. Particularly in oncology, precision targeted therapies targeting pathways such as EGFR, HER2, and programmed death-1/programmed death-ligand 1 have established robust models for biomarker-driven treatment. However, rapid advancements in diagnostic technologies, expanding application scopes, and increasingly complex mechanisms of biomar

The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer.

Chronic inflammation is now recognized as one of the major risk factors and molecular hallmarks of chronic prostatitis, benign prostatic hyperplasia (BPH), and prostate tumorigenesis. However, the molecular mechanisms by which chronic inflammation signaling contributes to the pathogenesis of these prostate diseases are poorly understood. Previous efforts to therapeutically target the upstream (e.g., TLRs and IL1-Rs) and downstream (e.g., NF-κB subunits and cytokines) inflammatory signaling molecules in people with these conditions have been clinically ambiguous and unsatisfactory, hence foster

Повторная оценка биопсии почек в связи с диабетической болезнью почек: гистопатология, курс клинической медицины и будущее точной нефрологии.

Фон: диабетическое заболевание почек (DKD) one :: основные причины хронических заболеваний и почечной недостаточности во всем мире. Хотя большинство пациентов, страдающих диабетом, диагностируются клинически на основе албуминурии, предполагаемого снижения уровня глумерной фильтрации и диабетической ретинопатии, одни только клинические параметры не могут надежно отличать биопсию, подтвержденную диабетической нефропатией (ННН), от недиабетической болезни почек (НДКД) или смешанных повреждений. Таким образом, биопсия почек для больных диабетом по-прежнему носит избирательный, а не рутинный характ

Совпадение в полном тексте источника
… Multi-omics is an umbrella term encompassing several complementary molecular profiling techniques including transcriptomics (the study of gene activity), proteomics (the study of proteins), metabolomics (the study of metabolic products), and epigenomics (the study of heritable changes in gene expression …

Дивергентные аутоиммунные генетические ландшафты у диабетиков и недиабетиков.

Тип фона 2 диабет (T2D) и аутоиммунные заболевания являются сложными расстройствами, формируемыми генетическими, иммунологическими и экологическими факторами. Однако различия в генетической восприимчивости к аутоиммунальным расстройствам между диабетическими и недиабетическими лицами по-прежнему плохо понимаются, особенно среди индийского населения. Цель этого исследования заключалась в сопоставлении полигенной подверженности множественным аутоиммунным заболеваниям между лицами с Т2D и без него из Гуджарата, Индия. eleven аутоиммунные заболевания в 474 отдельных лиц, включая 99 диабетические з

Совпадение в полном тексте источника
… Integration of multi-omics approaches, including transcriptomics, epigenomics, proteomics, and metabolomics, may further improve understanding of the shared immune-metabolic mechanisms underlying autoimmune susceptibility in diabetic individuals. …

Resveratrol downregulates interleukin-6-stimulated sonic hedgehog signaling in human acute myeloid leukemia.

IL-6 and sonic hedgehog (Shh) signaling molecules are considered to maintain the growth of cancer stem cells (CSCs). Resveratrol, an important integrant in traditional Chinese medicine, possesses certain antitumor effects. However, the mechanisms on regulating acute myeloid leukemia (AML) are unclear. This study first used human subjects to demonstrate that the plasma levels of IL-6 and IL-1 β in AML patients were higher and lower, respectively, than healthy donors. The expression of Shh preproproteins, and C- and N-terminal Shh peptides increased in bone marrow and peripheral blood mononuclea

Keyword Index for Volume 109

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Тип 1 Диабет и многоразовый склероз делятся общей генной переменой автономного иммунитета.

Справочная информация/цели: тип 1 диабет (T1D) и множественный склероз (MS) являются аутоиммунными, многофакторными, специфическими для органов расстройствами, обусловленными иммунными клетками. Их соучастие отчасти объясняется общими генетическими и экологическими факторами. Мы стремились расчленить общую генетическую архитектуру между T1D и MS с использованием крупномасштабных исследований по общегеномной ассоциации (GWAS) и анализа совместной локализации. Методы: Мы применили Байесовскую систему совместной локализации к two Крупномасштабные наборы данных GWAS: исследование T1D, включающее 1